Company: GEHC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001932393-25-000049
Chunk: 57

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 1
Chunk 57
---
2 %7 %41830.7 %37830.5 %11 %

____________________

*Non-GAAP Financial Measure

35

Table of Contents             

For the three months ended June 30, 2025

•Imaging Segment EBIT was $188 million, a decrease of $20 million primarily due to cost inflation, including the impacts of incremental tariffs, partially offset by cost productivity;

•AVS Segment EBIT was $267 million, an increase of $11 million due to growth in sales volume and cost productivity, largely offset by cost inflation, including the impacts of incremental tariffs;

•PCS Segment EBIT was $60 million, a decrease of $18 million primarily due to cost inflation and unfavorable mix, partially offset by cost productivity; and

•PDx Segment EBIT was $213 million, an increase of $14 million due to an increase in price and growth in sales volume, partially offset by increased investment.

For the six months ended June 30, 2025

•Imaging Segment EBIT was $387 million, an increase of $13 million due to cost productivity, growth in sales volume, and an increase in price, partially offset by cost inflation, including the impacts of incremental tariffs;

•AVS Segment EBIT was $528 million, an increase of $15 million due to growth in sales volume and cost productivity, largely offset by cost inflation, including the impacts of incremental tariffs;

•PCS Segment EBIT was $108 million, a decrease of $51 million due to cost inflation and unfavorable mix; and

•PDx Segment EBIT was $418 million, an increase of $41 million due to an increase in price and growth in sales volume, partially offset by increased investment.

NON-GAAP FINANCIAL MEASURES

The non-GAAP financial measures presented in this Quarterly Report on Form 10-Q are supplemental measures of our performance and our liquidity that we believe will help investors understand our financial condition, cash flows, and operating results, and assess our future prospects. When read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as one basis for making financial, operational, and planning decisions. Descriptions of the reported non-GAAP measures are included below.

We report Organic revenue and Organic revenue growth rate to provide management and investors with additional understanding and visibility into the underlying revenue trends of our established, ongoing operations, as well as provide